Notably, like CAFs, HCC TAMs have capacity to secrete fibronectin-1 through a Jun-dependent pathway, leading to increased metastasis, raising the question of whether this phenomenon may be conserved across all malignancies [25]. This evidence concerns the gene JUN and hepatocellular carcinoma.